# FDA Inspection 1111175 - BioGenetics Corporation - November 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/biogenetics-corporation/e1f882fc-92c8-4002-96dc-bf063d80895b
Source feed: FDA_Inspections

> FDA Inspection 1111175 for BioGenetics Corporation on November 12, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1111175
- Company Name: BioGenetics Corporation
- Inspection Date: 2019-11-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1266180 - 2025-03-14](https://www.keypedia.com/records/fda_inspections/biogenetics-corporation/16bb009f-3353-4699-b17b-2ec843dbcd2d)
- [FDA Inspection 1266180 - 2025-03-14](https://www.keypedia.com/records/fda_inspections/biogenetics-corporation/85d80d3f-7fa3-45cd-891c-c137970656f1)
- [FDA Inspection 1218002 - 2023-09-05](https://www.keypedia.com/records/fda_inspections/biogenetics-corporation/ecd745a1-5044-429a-b5f9-d38d07ac626e)
- [FDA Inspection 1218002 - 2023-09-05](https://www.keypedia.com/records/fda_inspections/biogenetics-corporation/3000531b-8da1-4e2b-bb7f-1e62d9fe92a6)
- [FDA Inspection 1111175 - 2019-11-12](https://www.keypedia.com/records/fda_inspections/biogenetics-corporation/979989eb-2a2a-4477-b361-7c3ef99ac52c)

Company: https://www.keypedia.com/companies/biogenetics-corporation/4321d0e2-4897-4883-bd09-07f2599d9433

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d